Toth Financial Advisory Corp Bristol Myers Squibb CO Transaction History

Toth Financial Advisory Corp

$825 Million
Q3 2024

A detailed history of Toth Financial Advisory Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Toth Financial Advisory Corp holds 56,977 shares of BMY stock, worth $3.27 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

56,977

Previous 51,258 11.16%

Holding current value

$3.27 Million

Previous $2.13 Million 38.53%

% of portfolio

0.36%

Previous 0.28%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$39.66 - $51.75 $226,815 - $295,958	5,719 Added 11.16%	56,977 $2.95 Million
Q2 2024 Jul 16, 2024	SELL	$40.25 - $52.99 $219,201 - $288,583	-5,446 Reduced 9.6%	51,258 $2.13 Million
Q1 2024 Apr 16, 2024	BUY	$47.98 - $54.4 $156,654 - $177,616	3,265 Added 6.11%	56,704 $3.08 Million
Q4 2023 Jan 26, 2024	SELL	$48.48 - $57.85 $1.41 Million - $1.68 Million	-29,093 Reduced 35.25%	53,439 $2.74 Million
Q3 2023 Oct 12, 2023	SELL	$57.89 - $64.73 $622,780 - $696,365	-10,758 Reduced 11.53%	82,532 $4.79 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $204,254 - $226,792	-3,206 Reduced 3.32%	93,290 $5.97 Million
Q1 2023 Apr 24, 2023	SELL	$65.71 - $74.53 $305,420 - $346,415	-4,648 Reduced 4.6%	96,496 $6.69 Million
Q4 2022 Jan 24, 2023	SELL	$68.48 - $81.09 $537,978 - $637,043	-7,856 Reduced 7.21%	101,144 $0
Q3 2022 Oct 14, 2022	BUY	$0.13 - $76.84 $850 - $502,764	6,543 Added 6.39%	109,000 $7.75 Million
Q2 2022 Jul 25, 2022	BUY	$72.62 - $79.98 $811,092 - $893,296	11,169 Added 12.23%	102,457 $7.89 Million
Q1 2022 Apr 26, 2022	BUY	$61.48 - $73.72 $1.27 Million - $1.52 Million	20,615 Added 29.17%	91,288 $6.67 Million
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $442,769 - $516,165	-8,256 Reduced 10.46%	70,673 $4.41 Million
Q3 2021 Oct 20, 2021	BUY	$59.17 - $69.31 $143,723 - $168,353	2,429 Added 3.18%	78,929 $4.67 Million
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $181,272 - $197,405	2,928 Added 3.98%	76,500 $5.11 Million
Q1 2021 Apr 20, 2021	BUY	$59.34 - $66.74 $238,487 - $268,228	4,019 Added 5.78%	73,572 $4.65 Million
Q4 2020 Jan 25, 2021	BUY	$57.74 - $65.43 $600,207 - $680,144	10,395 Added 17.57%	69,553 $4.31 Million
Q3 2020 Oct 16, 2020	BUY	$57.43 - $63.64 $887,638 - $983,619	15,456 Added 35.37%	59,158 $3.57 Million
Q2 2020 Jul 14, 2020	BUY	$54.82 - $64.09 $2.17 Million - $2.54 Million	39,554 Added 953.57%	43,702 $2.57 Million
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $107,648 - $156,437	-2,320 Reduced 35.87%	4,148 $231,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $57,477 - $74,973	1,168 Added 22.04%	6,468 $415,000
Q3 2019 Oct 15, 2019	BUY	$42.77 - $50.71 $226,681 - $268,763	5,300 New	5,300 $269,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.

Account

Toth Financial Advisory Corp Bristol Myers Squibb CO Transaction History